SURVODUTIDE
Minimum order 2 vials or 2 pens — delivery in 2 weeks
Dual GLP-1 and glucagon receptor agonist: in phase 2 (n=387) it produced up to −14.9% body weight at 46 weeks.
Illustrations of the product — not photos of a specific batch.
Take a breath. We're talking −14.9%, in 387 people, over 46 weeks 1 — numbers that need no decoration!
Dose-dependent, says the phase 2 study — the higher it went, the stronger the effect in the group.
A dual glucagon-GLP-1 agonist, in a clinical trial — science, not advertising.
Purity, though? That's where we never cut corners.
What we don't know: the long-term picture. Research use only — and we mean it!
−14.9%. 387 people. 46 weeks. Phase 2, dose-dependent 1. Not bro-science — a clinical number.
Dual glucagon-GLP-1 agonist. A clean mechanism.
No guarantee of results outside a controlled trial — we say it plainly.
Everything we sell is for research, purity certified.
What we don't know: long-term safety. Research use only, pure.
387 people, a phase 2 study, mean weight loss of up to −14.9% at 46 weeks 1.
Dose-dependent — the higher the dose, the bigger the change in the study group.
Survodutide is a dual glucagon and GLP-1 agonist, under clinical study.
What we don't know: long-term safety, and how it behaves outside a controlled trial.
Research use only, pure — no human dosing here.
Vial: 10 mg vial · Pens: 1 × 10 mg pen.
We don't keep it in stock — it's ordered in: minimum 2 items (vials or pens) from the special-order products, with free shipping, and it arrives in about 2 weeks.
€3 shipping + €3 cash-on-delivery fee. For orders of 2 vials or pens or more, shipping and the cash-on-delivery fee are free. Delivery time depends on the courier.
Cash on delivery, paid to the courier when it arrives. For an electronic money transfer (PayPal, Revolut, Wise, crypto), email us for the details: ellinikapeptidia@gmail.com
Yes: you have a 14-day right of withdrawal from delivery, as long as the seal is intact. Return costs are yours, unless the product was faulty or wrong. Terms of Use
Want something you don't see here? Write to us — we reply.
Related products
from €102.40 to €118.40
Minimum order 2 vials or 2 pens — delivery in 2 weeks
In a 48-week phase 2 RCT (263 adults with obesity), weekly eloralintide produced dose-dependent weight loss of up to −20% at the 9 mg dose, versus −0.4% with placebo.
from €44 to €176
Minimum order 2 vials or 2 pens — delivery in 2 weeks
−24.2% body weight in 48 weeks, and −82% liver fat. A triple GLP-1, GIP and glucagon agonist: it makes you eat less and burn more.
from €44 to €176
Minimum order 2 vials or 2 pens — delivery in 2 weeks
−20.9% body weight in 72 weeks, in a study of 2,539 people. A dual GLP-1 and GIP agonist: two switches instead of one — which is why the numbers are in a different league from monotherapy.
from €44 to €176
Minimum order 2 vials or 2 pens — delivery in 2 weeks
−14.9% body weight in 68 weeks — and the only one of the group proven to reduce heart attack and stroke, in 17,604 people.
from €79.20 to €140
Minimum order 2 vials or 2 pens — delivery in 2 weeks
It's not GLP-1 — it's amylin, the other satiety switch. Together with semaglutide it delivered −20.4% in 3,417 people.
from €112.80 to €128.80
Minimum order 2 vials or 2 pens — delivery in 2 weeks
GLP-1 and glucagon — no GIP. −14.0% in 48 weeks, and discontinuations due to side effects on par with placebo.
€0
Fill in and send. A person replies, not an automated message.